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Summary Clinical factors were studied in a population based survey of 1,1 16 cases of testicular neoplasms in
Victoria, Australia, between 1950 and 1978. The ratio of right to left sided tumours was 54:46, but the left side
predominated among sarcomas (P = 0.006), and in older men. The relative risk (RR) for men with unilateral
maldescent was 15 (CI 10-23) and for men with bilateral maldescent 33 (CI 20-55) (odds ratio 1.4, CI 0.5-4,
P = 0.7). Calculations per testis in men with unilateral maldescent showed an elevated risk for both the
maldescended testis (RR 28, CI 19-41, P<0.0001) and the normally descended testis (RR 3, CI 1.2-6,
P = 0.04). The RR for men with abdominal maldescent was 55 (CI 36-83) compared to 7 (CI 4-11) for those
with inguinal maldescent (odds ratio 8, CI 3-20, P<0.0001). Seminomas were more common than non-
seminomas (NSGCT) in men with a history of maldescent (odds ratio 1.7, CI 1.1-3, P = 0.02) and also
among corrected cryptorchids compared to uncorrected (P = 0.005). Seminomas were diagnosed at an earlier
median age in men with corrected cryptorchid testes compared to uncorrected (P = 0.03) and in men with
corrected cryptorchid testes compared to normally descended (P = 0.001). Maldescent was also associated with
hernia (P = 0.04). Twenty-eight per cent of patients recorded a history of trauma with a higher proportion
among NSGCT than among seminomas (P = 0.03). Prior malignancies were reported in nine patients,
compared to 3.6 expected; prostate cancer (2) and malignant melanoma (2) were the greatest contributors to
the excess.
Studies of testis cancer have revealed associations with a
number of clinical conditions, some of which are claimed to
be aetiologically significant. Cryptorchidism is the best estab-
lished risk factor (Pugh, 1976; Mostofi, 1973; Blandy et al.,
1970) but the reason for this association remains to be fully
elucidated. A history of mumps or mumps orchitis and other
urogenital conditions such as hernia, testicular atrophy and
hydrocoele, hormone imbalances and trauma have all been
proposed as playing a part in the aetiology of testicular
malignancy, together with a number of infections and
medical conditions (Pottern et al., 1985; Coldman et al.,
1982; Beard et al., 1977; Schottenfeld et al., 1980; Henderson
et al., 1979; Field, 1963). However evidence in relation to
these conditions is contradictory. No epidemiological studies
of these issues have been reported in Australia. The present
paper reports on clinical factors investigated in a population
based survey of the incidence of testicular cancer in the State
of Victoria from 1950 to 1978.
Materials and methods
In an attempt to identify all new cases of testis cancer
occuring in Victoria between 1950 and 1978, a number of
resources were utilised. The medical histories at Peter Mac-
Callum Cancer Institute (PMCI), the major Victorian cancer
therapy institute, provided the initial data base. Private case
histories of one of us (TFS) and 13 other radiotherapists
associated with the PMCI were also searched. Since orchidec-
tomy is performed on most testis cancer patients, pathology
records offered an effective method of ascertainment of addi-
tional cases. Records of 27 public hospitals, 12 private path-
ology services, two university pathology departments, the
Royal Australian College of Surgeons and the Royal Aust-
ralian Navy were therefore searched. All pathologists who
performed histology for the Victorian population during the
period gave access to data, except for one small private
service which was no longer operating. In addition, 362 death
certificates relating to testis cancer were obtained from the
Victorian Registrar of Births, Deaths and Marriages, from a
list supplied by the Australian Bureau of Statistics. A full
description of case ascertainment is given in Stone et al.
(1991).
For the purpose of investigation of clinical associations
and risk factors, we selected cases diagnosed in the period
1950-1978, resident in Victoria and with a malignancy
primary in the testis defined according to the rules of the
International Classification of Diseases (World Health
Organization, 1967). This specifically excludes lymphomas.
The date of diagnosis was defined as the date of orchidec-
tomy, biopsy of metastasis or post-mortem. In the absence of
pathological evidence, the date of diagnosis on a clinical
basis was used. Unless otherwise specified bilateral tumours
were treated as a single case, the first malignancy being used
for analysis when they were not simultaneous.
Wherever possible, histological material was reviewed at
PMCI, or failing that all accessible clinical information, in-
cluding the original pathology report, was reconsidered. The
system of classification was that of the British Testicular
Tumour Panel (Pugh, 1976) and other terminology was con-
verted where necessary, using the table provided in that
publication. The main division used in the present analysis
was seminoma, non-seminoma germ cell (NSGCT) and
other, which is common to all systems. Where they are not
specified separately, cases whose histology could not be
determined on review have been grouped with non-germ cell
tumours.
All testes which were reported to be abdominal or inguinal
at birth were defined as having a history of maldescent. This
included testes which descended spontaneously some time
after birth but excluded those described as retractile. As most
medical histories relied on information from the patient,
under-reporting is likely.
All denominators exclude cases with missing data for the
relevant factor. Data analyses were performed on a Micro-
Vax 2 with VMS version 4.7 using BMDP Statistical Package
(Dixon et al., 1988) or purpose written programs. Ninety-five
per cent confidence intervals (CI) are given in brackets where
appropriate. Expected numbers of prior malignancies were
based on the earliest available Australian data, incidence and
mortality figures for New South Wales for 1973-77 and 1977
respectively (Ford et al., 1982; New South Wales Central
Cancer Registry, 1981). Unless otherwise stated, Chi-squared
tests for contingency tables were used to test associations
between pairs of factors; tests for trend were incorporated
where appropriate.
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Results
The search resulted in the identificaiton of 1,116 cases of
testicular malignancy among Victorian residents in the period
1950-1978 (Figure 1).
Laterality
Fifty-four per cent of tumours overall were right-sided and
this remained virtually constant over the time period (P =
0.80, test for linear trend). The proportion of right-sided
tumours varied between histological sub-types overall (P =
0.02) (Table I). Most deviant were sarcomas (P = 0.006 sar-
comas compared to the rest of the series combined). The
proportion also varied with age, the right-side predominating
in the juvenile group and the left in those 55 and older
(Table II). There were 18 cases of bilateral tumours (1.6%),
four of these being simultaneous and 14 sequential.
Maldescent
The data on 778 cases for which maldescent status was
available were analysed in some detail for associations with
malignancy (Table III). A history of cryptorchidism was
reported in 100 cases (13%). Of these, in five cases (5%) the
testes had descended spontaneously before puberty, and in
nine cases (9%) at or after puberty. Of the remainder, the
maldescended testes were inguinal in 33 cases (33%) and
abdominal in 53 cases (53%). In six cases the side of malig-
nancy was contralateral to the side of maldescent. One man
with bilateral non-simultaneous malignancies experienced the
first tumour in a normally descended testis and the second in
the maldescenced testis. A larger proportion of men with
bilateral disease (31%) had a history of maldescent than did
those with a unilateral malignancy (12%) (P = 0.04, Fisher
exact test). The reported frequency of maldescent dropped
from 21% in 1950-59 to around 12% in the later two
decades (Table IV).
Relative risks for paired organs can be calculated either by
considering the risk for the individual organ, or by consider-
ing the risk for the person. In a man with unilateral mal-
descent, both the maldescended testis (RR 28, CI 19-41,
P<0.0001) and the opposite (normally descended) testis (RR
3, CI 1.2-6, P = 0.04) had elevated risks of developing a
tumour, relative to a testis in a man with no maldescent. The
Table I Histology and side of tumour at first presentation
Side of tumour
Histology Left (%) Right (%) Bilateral (%) Total
Seminoma 248 (46) 294 (54) 3 (< 1) 545
NSGCT 187 (43) 251 (57) 1 (< 1) 439
Teratoma 156 (45) 192 (55) 0 (0) 348
Combined 25 (35) 46 (64) 1 (1) 72
Yolk sac tumour 6 (32) 13 (68) 0 (0) 19
Non germ cell 21 (72) 8 (28) 0 (0) 29
Sarcoma 10 (91) 1 (9) 0 (0) 11
Other 11 (61) 7 (39) 0 (0) 18
Unknown 7 (58) 5 (42) 0 (0) 12
Total 463 (45) 558 (54) 4 (< 1) 1025
NSGCT = non-seminoma germ cell tumour; Combined = semin-
oma + teratoma. Table excludes 91 cases for which the side of the
tumour is not known. Non-simultaneous bilateral tumours are
categorised under the side of first tumour.
cses
Histology reviewed at PMCI
-Histologically confirmed 935 (86%)
1082 (97%)
052 orrhidectomy Histology not reviewed at PMCI
24 meiastases Pathology reports available
6 post mortem 134 (12%)
Histology not reviewed at PMCI
No pathology report available
13 (1%)
-Clinical records
5 (<1%)
29 (3%)
Figure 1 Review status of identified cases of testicular cancer in
Victoria, Australia, 1950-1978. PMCI: Peter MacCallum Cancer
Institute.
risk was significantly greater for the maldescended testis
(odds ratio 10, CI 4-27, P<0.0001). There was no signi-
ficant increase in risk for an individual testis in a man with
bilateral maldescent (RR 38, CI 24-62, P<0.0001) com-
pared to a man with unilateral maldescent (odds ratio 1.4, CI
0.5-4, P = 0.7).
The remainder of the calculations pertaining to maldescent
were carried out considering the risk for the man (Table V).
A man with a history of maldescent was estimated to have 18
times (CI 12-26, P<0.0001) the risk of developing a
tumour, whether ipsi lateral or contralateral, compared with
a man whose testes had descended normally. Men with
bilateral maldescent had a greater RR than did those with
unilateral maldescent, but the difference was not statistically
significant (odds ratio 2, CI 0.8-6, P = 0.2). The risk was
significantly higher (odds ratio 8, CI 3-20, P<0.0001) for
men who testes were retained in the abdomen (RR 55, CI
36-83, P<0.0001) than for those with inguinal testes (RR 7,
CI 4-11, P<0.0001).
An association between maldescent and histology of the
neoplasm was observed. Men with maldescent were more
likely to develop a seminoma than NSGCT (odds ratio 1.7,
CI 1.1-3, P=0.02) relative to men without maldescent.
The proportion of patients whose maldescended testes had
been surgically corrected by orchidopexy increased over the
time period (Table IV). The age at the operation was known
Table III Laterality and maldescent status
Laterality ofmalignancy
Maldescent status Unilateral (%) BilateraP (%) Total (%)
Normal 667 (88) 11 (69) 678 (87)
Maldescent 95 (12) 5 (28) 100 (13)
Unilateral 75b (10) 1 (6) 76 (10)
Bilateral 20 (3) 4 (25) 24 (3)
Unknown 336 2 338
Total 1098 18 1116
Percentages are of all cases with known maldescent status. aSimul[
taneous and non-simultaneous bilaterals; b69 ipsilateral and six contra-
lateral malignancies.
Table II Laterality, histology and age at diagnosis
Seminoma NSGCT Other Total
Age No. % Right No. % Right No. % Right No. % Right
< 15 0 0 17 76 3 0 20 65
15-34 193 54 292 54 12 25 497 53
35-54 295 56 110 64 13 46 418 58
55 + 47 45 14 50 12 33 73 44
Total 535 54 433 57 40 32 1008 55
NSGCT = non-seminomagermcelltumour. Tableexcludesfoursimultaneousbilateral
tumours and 104 cases with unknown age and/or side. Non-stimultaneous bilateral
tumours categorised under the side of the first tumour.
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Table IV Maldescent and orchidopexy by time periods
Category 1950-59 (%) 1960-69 (%) 1970-78 (%) Total (%)
All cases 226 439 451 1116
Known mald. 87 (38) 324 (74) 367 (81) 778 (70)
Maldescenta 18 (21) 37 (11) 45 (12) 100 (13)
Abdominalb 10 (63) 19 (59) 24 (63) 53 (62)
Orchidopexyc 3 (20) 12 (34) 28 (68) 43 (47)
Known mald. = known maldescent status. aPercentages are of all cases with known
maldescent status;bPercentages areofallmaldescended cases;cPercentages areofallcases
with known orchidopexy status.
Table V Relative risk according to histology and maldescent factors
Seminoma NSGCT Total
Maldescent status No. RR 95% CI No. RR 95% CI No. RR 95% CI
Total cases 431 - - 330 - - 778
Normal descent 364 1 - 298 1 - 678 1
Maldescent 67 22 14-33 32 13 8-21 100 18 12-26
Unilateral 53 20 13-30 22 10 6- 17 76 15 10-23
Bilateral 14 36 20-67 10 32 16-64 24 33 20-55
Inguinal mald. 25 10 6-16 7 3 2-8 33 7 4-11
Abdominal mald. 33 64 40-102 20 47 27-82 53 55 36-83
NSGCT = non-seminoma germ cell tumour; RR= relative risk; CI = confidence interval;
mald = maldescent. Relative risks calculated using an estimated population frequency for Victoria
formaldescent at birth of0.83 per 100 (Drew etal., 1977); an estimate that 17% ofectopic testes are
abdominal (derived from Scorer& Farrington, 1971); and assuming 13% ofmaldescended testes are
bilateral (derived from Scorer & Farrington, 1971). Total includes 17 non germ cell tumours.
Maldescent includes ipsilateral, contralateral and bilateral.
for 37 cases; the median was 12 years and the age range 2 to
29 years. The malignancies occurred in these patients
between 1 and 50 years after orchidopexy with a median
interval of 16 years. The proportion of germ cell tumours
that were seminomas was significantly higher among testes
which were still in an abnormal position at diagnosis (85%)
compared to those surgically placed in the scrotum (53%)
(P = 0.005) or those scrotally located regardless of the mode
of entering the scrotum (55%) (P = 0.001) (Table VI).
The distributions of age at diagnosis for maldescended and
normally descended germ cell tumours are presented in
Figure 2a and b. Among seminomas the median age at
diagnosis of men with maldescent was lower than among
those with normal descent (P = 0.001, Mann-Whitney test)
whereas among NSGCTs the difference was not significant
(P = 0.23) (Table VI). Men whose maldescent had been cor-
rected by orchidopexy were diagnosed at an earlier age than
those whose maldescent was not corrected (seminomas
P = 0.03, NSGCTs P = 0.05) and at an earlier age than those
with no history of maldescent (seminomas P = 0.001,
NSGCTs P = 0.15). Men whose testes had descended spon-
taneously after birth were also younger at diagnosis than
those with normal descent (seminomas P = 0.02, NSGCTs
P = 0.57). For both seminomas and NSGCTs, men with
abdominal maldescent were younger than those with inguinal
maldescent, but the differences did not reach statistical
significance (seminomas P = 0.25, NSGCTs P = 0.24).
Finally it was observed that maldescent was significantly
associated with hernia. A hernia was recorded in 30 (5%) of
578 cases without a history of maldescent, compared to ten
(11%) of 87 cases with maldescent (P = 0.04).
Trauma and other clinicalfactors
The frequency of a recorded history of trauma was 28%
(219/782) with a higher proportion among NSGCT (106/
333 = 32%) than among seminoma patients (106/430 = 25%)
(P = 0.03). The median interval between trauma and date of
diagnosis was 1 year or less, with a range of 0 to 61 years.
Nine patients reported other malignancies prior to the
diagnosis of testicular cancer. The expected number of prior
malignancies (all cancer except testis) was estimated to be
3.6, giving a ratio of observed to expected cases of 2.5. There
were two cases of prostate cancer (0.2 expected), two of
Table VI Median age at diagnosis according to histology and maldes-
cent status
Seminoma NSGCT Total
Maldescent Median Median Median
status No. age No. age No. age
Normal 368 39 301 29 685 34
Maldescended 63 35 29 27 93 32
Late descent 8 32 5 25 13 27
Inguinal 24 37 6 33 31 37
Abdominal 31 32 18 27 49 31
Orchidopexy 20 32 18 27 38 29
No orchidopexy 28 39 5 36 33 38
Scrotal 396 38 324 29 736 34
Totala 431 38 330 29 778 34
NSGCT = non-seminoma germ cell tumour. Scrotal = all testes in
thescrotumatpresentation, includingnormal, spontaneousdescentand
orchidopexy. The age ofone normally descended case with seminoma
was unknown. Maldescended includes ipsilateral and bilateral; contra-
lateral maldescended included with normal. Total includes non-germ
cell tumours. 'All cases with known maldescent status.
malignant melanoma (0.08 expected), one acute myeloid
leukaemia (0.1 expected) and one case each of bladder (0.3
expected), brain (0.4 expected), colon (0.3 expected) and
salivary gland tumours (0.04 expected). No associations were
observed for a history of mumps, orchitis, atrophy, Down's
syndrome, mental retardation or cerebral palsy.
Discussion
Laterality
A predilection for the right side is a well established although
unexplained feature of testis cancer. Our result of an overall
predominance of right sided tumours of 54% is consistent
with the ratio of 5:4 (56%) in.most reported series (Kuhn &
Johnson, 1972). The later and less complete descent of the
right testis may suggest an aetiological connection between
maldescent and laterality of germ cell tumours (Blandy et al.,
1970; Kuhn & Johnson, 1972). A variation in laterality
according to age groups was also observed by Spitz et al.
(1986). The variation in laterality according to histologicalLATERALITY, MALDESCENT AND TRAUMA IN TESTIS CANCER 135
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Figure 2 a, Age distribution of normal and maldescended semi-
nomas. One case with unknown age excluded. Normal = 367
cases, median age 39, age range 18-84. Maldescended = 63 cases,
median age 35, age range 19-58. b, Age distribution of normal
and maldescended non-seminomas germ cell tumours. Normal =
301 cases, median age 29, age range 0-75. Maldescended = 29
cases, median age 27, age range 0-52.
type was marked. Among yolk sac tumours and combined
seminomas and teratomas there were more right-sided malig-
nancies than average, while among tumours of the gonadal
stroma and markedly among sarcomas, the left-side predom-
inated. Some authorities are of the opinion that the primary
site of all testicular sarcomas is the spermatic cord (Pugh,
1976). An effort was made in this study to exclude tumours
known not to be primary in the testis. However, if the 11
sarcomas can be regarded as originating in the cord, a tenta-
tive hypothesis for their observed left-sided predominance
might be found in the fact that the left testis usually hangs
lower and therefore has more spermatic cord at risk.
The occurrence of bilateral malignancy is similar in this
study to other reported series (Blandy et al., 1970). As others
have found, the majority are asynchronous. Synchronous
bilateral germ cell tumours are rare (Miles et al., 1985). One
of our four cases was unusual in having different histology
on each side - the left was pure seminoma and the right
teratoma intermediate. In this study, cryptorchidism was
significantly more common among men with bilateral disease.
Thirty-one per cent of our patients experiencing a second
tumour had a history of maldescent compared to 46%
reported by Senturia (1987).
Maldescent
Maldescent is now well established as a risk factor for tes-
ticular malignancy. Our observation that 13% of cases over-
all had a recorded history of maldescent is consistent with an
average of approximately 9% recorded in the literature (Chil-
vers et al., 1986), and is virtually identical to the 13.1%
reported in an early joint Australian and UK series (Gordon-
Taylor & Wyndham, 1947).
The summary by Chilvers and her colleagues (Chilvers et
al., 1986) of the literature on aspects of cryptorchidism
among series of testicular tumours provides a convenient
point of comparison with the present series. Our frequency of
nine (1.2% of total) of spontaneous descent at or after
puberty is similar to the literature average of 1.5%. Our
frequency of 53% for abdominal maldescent is high com-
pared to the published reports. In early series, approximately
45% of testicular malignancies are abdominal and more
recent ones only 18%. The frequency with which the tumour
developed in the normally descended testis of patients with
unilateral malignancy (7/76 = 9%) contrasts with 3% in an
early series and 17% in later papers.
Variations in the degree of care with which the history was
taken probably contributes to discrepancies among published
reports. Differences will also occur according to whether
frequencies are reported as percentages of all cases or only of
cases with known status. In the present series, many cases
lacked any written report, and therefore the unknowns can-
not be assumed to be negative. For this reason in our
calculations denominators consisted of all cases where the
relevant status was known, in the belief that this would result
in an estimation closer to the true proportion. The high
proportion of maldescent (61%) in the period 1950-59 is
almost certainly a reflection of the large amount of missing
data in that period, and the overall frequency of maldescent
is thus probably over-estimated.
Another methodological point worth noting relates to the
inconsistencies among published reports on the question of
an age difference between cryptorchid and normally descend-
ed malignancies. These may be a consequence of the tradit-
ional use of age of peak incidence, which is a misleading
summary statistic. In our series, for both types of germ cell
tumours, the age of peak incidence is later among patients
with a history of maldescent, yet the median age is earlier.
Estimates of the increased risk of malignancy associated
with maldescent vary substantially depending on the study
method. Those that require an estimate of the frequency of
maldescent in the population generally result in a compara-
tively high calculated risk (e.g. Blandy et al. (1970) with a
risk of 30 and Mostofi (1973) with a risk of 14). The overall
RR of 18 calculated in the present study is of a similar order.
Case control studies generally produce lower calculated risks.
Pottern et al. (1985) for instance found a RR of 4.2 and
Swerdlow et al. (1987) 6.3. A different approach was taken
by Giwercman et al. (1987) who studied malignant outcomes
in a cohort of boys with cryptorchidism. Their observed RR
of 4.7 is similar to that found in case control studies. It is
probable that the discrepancy is at least partly due to the fact
that estimates of prevalence ofcryptorchidism in the popula-
tion vary depending on the age at which the subjects are
examined. Whitaker (1970) showed that frequency of maldes-
cent drops from around 20% in premature babies, to 2% in
full term babies, to about 0.3% in adults. In a given study, a
lower population estimate of maldescent will result in a
higher RR. The Australian estimate of 0.83% at birth (Drew
et al., 1977) used in the present study is low by comparison
(Table V).
When comparing risks for bilateral and unilateral maldes-
cent, the estimate used for occurrence of bilateral maldescent
in the population is also critical. We used an estimate of 13%
calculated from data presented by Scorer and Farrington
(1971). Schottenfeld and Warshauer (1982) give a ratio of 4:1
for the occurrence of unilateral to bilateral maldescent. Use
of this ratio in our calculations would result in RRs of 17 for
unilateral maldescent and 21 for bilateral, compared to 15
and 33 respectively (Table V).
The definition of cryptorchidism is also of importance. It
has been observed that a narrow definition results in a much
higher estimated risk, whereas a much broader definition
including retractile organs reduces it (Depue et al., 1986). We
defined a history of maldescent as cryptorchid at birth
excluding retractile. Despite the comparatively broad defini-
tion a comparatively high relative risk was calculated.
One issue raised by observations of an association between
maldescent and carcinogenesis is whether the effect is due to
the location of the testis or to an abnormality in the mal-
descended testis itself. The present data present conflicting
evidence on this subject. The markedly greater RR of
abdominal cryptorchidism (RR = 55, CI 36-83) than ingui-
nal cryptorchidism (RR= 7, CI 4-11) strongly suggests an
effect associated with the site of arrest, although it might also
be argued that testes which have descended partially are less136 J.M. STONE et al.
abnormal than those retained in the abdomen. In addition,
there were differences in the median ages at diagnosis of the
two groups (Table VI) with malignancy occurring at an
earlier age in abdominal testes than in the inguinal organs.
Although the difference was not significant, this may suggest
that carcinogenesis was hastened in the abdominal testes.
Evidence for a site related effect is also contained in the
observation that the location of the testis was strongly
associated with the histology of the neoplasm. One possible
explanation for this is that the trauma of surgical interven-
tion is a factor in the differing histology between corrected
and uncorrected cyptorchid malignancies, and the significant
association found between trauma and histology is consistent
with this. However, the association between histology and
site was demonstrated irrespective of the means by which the
testis reached the scrotum. The reason for this is not appar-
ent but it does suggest that a factor associated with the
location of the testis influences carcinogenesis.
If the location of the testis were the critical factor in
carcinogenesis associated with maldescent, then men with
bilateral maldescent could be expected to have a higher
relative risk than men with unilateral maldescent. In our
study there was no significant difference in RR between the
two groups. The analysis of age of occurrence (Table VI)
also tends to support the argument that the abnormal loca-
tion itself is not the causal factor in tumour development in
maldescended testes, at least not to the extent of hastening
carcinogenesis (Batata et al., 1976, 1982). Although the testes
of men who have undergone orchidopexy are scrotally
located, their median age was younger than that of men with
normal descent, significantly so among seminomas. These
men were also younger than those whose maldescent had not
been surgically corrected, apparently suggesting that carcino-
genesis was acutally hastened by orchidopexy. One alterna-
tive explanation for this finding may be that testes in the
scrotal position are more readily accessible to observation,
resulting in the earlier detection of symptoms and seeking of
medical advice. When the testis is abdominal, the diagnosis
might not be made until later. A further explanation might
derive from the increasing frequency of orchidopexy (Mac-
kellar et al., 1983) and the tendency for testicular cancer to
occur at a younger age over recent decades (Senturia, 1987).
Both these processes occurred in the subject population of
this study (Stone et al., 1991) and might thus have produced
a spurious association between orchidopexy and age.
It is well established that the incidence of testicular cancer
is increasing internationally (Brown et al., 1987). It has also
been observed that the rate of occurrence of maldescent is
rising in England and Wales (Chilvers et al., 1989). If maldes-
cent were the sole factor responsible for the increasing
incidence of testicular cancer, the proportion with maldescent
should have increased over the time period. However Chil-
vers et al. (1989) concluded from the published literature that
the proportion of testicular cancer patients with maldescent
has remained approximately constant over time. This sug-
gests that the other factors giving rise to testicular cancer are
increasing at the same rate as maldescent, and hence may
share a common aetiology. The finding by us and others of
an increased risk of cancer in the normally descended testis
contralateral to maldescent also suggests a common develop-
mental abnormality.
Our finding of a statistically significant association between
a history of hernia and of maldescent is in agreement with
published reports (Schottenfeld et al., 1980; Morrison, 1976).
The embryological basis for such an association is well estab-
lished as being due to the physical mechanism of faulty
descent which virtually produces a hernia (Davey & Hamil-
ton, 1972; Shapiro & Bodai, 1978).
Orchidopexy
The observed increase in frequency of orchidopexy over the
time period (Table IV) supports observations that the prac-
tice is increasing (John Radcliffe Hospital Cryptorchidism
Study Group, 1986; Mackellar et al., 1983).
Whether orchidopexy affects the risk of subsequent malig-
nancy is a controversial question. Pottern and her group
(Pottern et al., 1985, 1986) considered that their data demon-
strated a significantly increasing risk with increasing age at
correction. However their test measured the joint effect of
cryptorchidism and of its treatment (Depue et al., 1986; Pike
et al., 1986) and although their data were consistent with an
increasing risk the test for trend was not significant (one
sided P-value of 0.2).
We were unable to calculate the risk at different ages of
orchidopexy due to unavailability of appropriate population
data. However an indirect test of the reduction in risk of
testis cancer associated with orchidopexy was described by
Depue et al. (1986). While orchidopexy might lower the risk
for both the cryptorchid and the contralateral testis, any
effect might be expected to be greater for the cryptorchid
testis; thus the proportion of cancers in the cryptorchid testis
compared to the contralateral testis would be smaller for
patients with corrected cryptorchidism. In our series the
opposite was true: proportionately more tumours developed
in the cryptorchid testis of patients who had previously
undergone orchidopexy (27/29 = 93%), than among uncor-
rected cryptorchids (23/27 = 85%). This same anomaly was
observed in both the series analysed by Depue et al. (1986).
The odds ratio of 2.2 (Mantel-Haenszel estimate) obtained
from combining the data in our series with the two reported
series is not significantly greater than one (P = 0.07). How-
ever this result suggests that orchidopexy may acutally be
putting young men at a greater risk of developing testis
cancer, at least at the ages at which it was performed in our
study population. Only three of our cases had undergone
orchidopexy before the age of 5. While our data give no
information on the value of orchidopexy before 5 years, they
do support an argument against orchidopexy at older ages.
Trauma
The frequency of a reported history of trauma is high in this
study (28%) and may be due to a tendency for those with a
noteworthy experience to volunteer information while the
absence could go unremarked. The only published report with
a similar frequency is that of Brown et al. (1987) who found
trauma in 79/271 cases (29%). Their case control study
demonstrated a significantly elevated RR of 2.6. The general
tendency for patients to attribute any illness to past injury is
perhaps accentuated with such a sensitive organ as the testi-
cle (Blandy et al., 1970). Howden (1968) notes that injury to
the testicle is especially common in countries where rugby is
played, such as New Zealand. Australian Rules football is a
similarly vigorous contact sport and its popularity in Victoria
might account for the high frequency of reported trauma
among our patients. It is relevant to note the statistically
significant relationship with cycling and horse-riding found in
a British case control study (Coldman et al., 1982) which
implies an association with trauma. However Swerdlow et al.
(1988) failed to find any significant association with trauma
due to sports or potentially traumatic modes of transport.
Our observation that NSGCTs were more likely to be
associated with a history of trauma to the testis deserves
note. A spurious association would be more likely to occur
with seminoma patients since they are on average older, and
the tumours have a tendency to develop over a longer period
and to be larger. These men are therefore more likely to give
a history of trauma than those with NSGCTs. The fact that
the reverse has been observed in this series lends weight to
the argument that the relationship between trauma and testi-
cular malignancy is not artifactual. On the other hand, for
half the men the diagnosis of testicular malignancy occurred
1 year or less after the reported trauma. Such a short interval
is unlikely if the relationship is causal.
Prior malignancies
The finding of an increased number of previous cancers is of
interest. While it is consistent with observations that cancerLATERALITY, MALDESCENT AND TRAUMA IN TESTIS CANCER 137
patients have an elevated risk of a second cancer (Curtis et
al., 1985), the larger than expected number of previous pros-
tate cancers is noteworthy given that this malignancy gener-
ally occurs at a later age than testis cancer. Other authors
have found an association between testis cancer and lym-
phatic malignancies (leukaemia and non-Hodgkin's lym-
phoma) (Curtis et al., 1985; Kleinerman et al., 1985). Newell
et al. (1984) drew attention to striking epidemiological simi-
larities between cancer of the testis and Hodgkin's disease
and suggested that viral infection might be common to both.
Common aetiological mechanisms might contribute to the
associated occurrence of these malignancies.
Conclusion
In conclusion, evidence of the factors determining the rela-
tionship between cryptorchidism and testicular malignancy
remains contradictory and confusing. There is some support
for the existence of a carcinogenesis initiating or promoting
factor in the micro-evironment of the testis itself in our
demonstration of a higher relative risk for abdominal than
inguinal testis cancer, in their earlier median age at diagnosis
and in the association between location and histology. It has
been suggested that this factor might be the increased temp-
erature the testis experiences in the body cavity as compared
to the normal scrotal position (Mostofi, 1973). However
more recent case control studies have failed to find signifi-
cantly raised risks with various indicators of testicular
temperature (Swerdlow et al., 1988).
On the other hand there is considerable evidence for an
underlying factor common to maldescent and malignancy.
The developmental abnormality might be gonadal dysgenesis
(Senturia, 1987), a systemic factor such as hormone exposure
in utero (Henderson et al., 1979), or a chromosomal abnor-
mality (Robson et al., 1981). Carcinoma in situ has been
found in the contralateral testis of men with testicular
tumours, regardless of maldescent status. This also supports
the argument for a systemic factor (Berthelsen et al., 1979).
The relationship of cryptorchidism to neoplasia remains
elusive and has been linked to a matrix of factors including
atrophy and hernia. Our results indicate that laterality might
also be implicated and should be incorporated in future
studies. Senturia (1987) concluded her literature review of the
subject with the proposition that the most likely origin is
gonadal dysgenesis and suggested cryptorchidism may be a
promoter. The results of the present study are consistent with
such a model.
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